Disrupted nighttime sleep and sleep instability in narcolepsy.

Kiran Maski, Emmanuel Mignot, Giuseppe Plazzi, Yves Dauvilliers

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2022;18(1):289-304

PMID: 34463249

Abstract

STUDY OBJECTIVES

This review aimed to summarize current knowledge about disrupted nighttime sleep (DNS) and sleep instability in narcolepsy, including self-reported and objective assessments, potential causes of sleep instability, health consequences and functional burden, and management.

METHODS

One hundred two peer-reviewed publications from a PubMed search were included.

RESULTS

DNS is a key symptom of narcolepsy but has received less attention than excessive daytime sleepiness and cataplexy. There has been a lack of clarity regarding the definition of DNS, as many sleep-related symptoms and conditions disrupt sleep quality in narcolepsy (eg, hallucinations, sleep paralysis, rapid eye movement sleep behavior disorder, nightmares, restless legs syndrome/periodic leg movements, nocturnal eating, sleep apnea, depression, anxiety). In addition, the intrinsic sleep instability of narcolepsy results in frequent spontaneous wakings and sleep stage transitions, contributing to DNS. Sleep instability likely emerges in the setting of orexin insufficiency/deficiency, but its exact pathophysiology remains unknown. DNS impairs quality of life among people with narcolepsy, and more research is needed to determine its contributions to cardiovascular risk. Multimodal treatment is appropriate for DNS management, including behavioral therapies, counseling on sleep hygiene, and/or medication. There is strong evidence showing improvement in self-reported sleep quality and objective sleep stability measures with sodium oxybate, but rigorous clinical trials with other pharmacotherapies are needed. Treatment may be complicated by comorbidities, concomitant medications, and mood disorders.

CONCLUSIONS

DNS is a common symptom of narcolepsy deserving consideration in clinical care and future research.

CITATION

Maski K, Mignot E, Plazzi G, Dauvilliers Y. Disrupted nighttime sleep and sleep instability in narcolepsy. . 2022;18(1):289-304.

© 2022 American Academy of Sleep Medicine.

Address: Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.; Stanford Center for Sleep Sciences and Medicine, Redwood City, California.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio-Emilia, Modena, Italy.; IRCCS, Istituto delle Scienze Neurologiche, Bologna, Italy.; National Reference Network for Narcolepsy, Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, Montpellier, France.; University of Montpellier, INSERM Institute for Neurosciences Montpellier, Montpellier, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.